Swaminathan P iyer

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Swaminathan P iyer

Feb 20, 2025, 08:27 | Blog

Yan Leyfman: Off-the-shelf CAR T cells could be a viable option for R/R T-cell Lymphoma

Yan Leyfman, Co-founder and executive director of MedNews Week, shared an article Swaminathan P. Iyer and colleagues…

Jan 29, 2025, 18:14 | Science

Charles Gaulin: Phase 2 trial of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma

Charles Gaulin, Hematologic Oncologist at Dartmouth Hitchcock Medical Center and Clinics, shared his recent article…

All: 2 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023